Given the importance of EGF/EGFR and HGF/Met signaling in HCC progression and drug resistance [5], we performed immunoblotting analysis to evaluate the level of phosphor- and total EGFR and -c-Met in HCC cells after USP8 inhibition. This evidence concerns the gene MET and hepatocellular carcinoma.